TipRanks
Advertisement
Advertisement

AU:LDX Stock Latest News

Lumos Diagnostics Options Lapse, Simplifying Capital Structure
Company AnnouncementsLumos Diagnostics Options Lapse, Simplifying Capital Structure
3d ago
LDX
Lumos Diagnostics Issues New Shares on Employee Option Exercise, Confirms Compliance
PremiumCompany Announcements
Lumos Diagnostics Issues New Shares on Employee Option Exercise, Confirms Compliance
12d ago
LDX
Lumos Diagnostics Issues New Shares After Ryder Capital Option Exercise
PremiumCompany Announcements
Lumos Diagnostics Issues New Shares After Ryder Capital Option Exercise
27d ago
LDX
Lumos Diagnostics Seeks ASX Quotation for 26 Million New Shares
PremiumCompany Announcements
Lumos Diagnostics Seeks ASX Quotation for 26 Million New Shares
27d ago
LDX
Lumos accelerates U.S. FebriDx rollout across major urgent care networks
PremiumCompany Announcements
Lumos accelerates U.S. FebriDx rollout across major urgent care networks
27d ago
LDX
Lumos Diagnostics Issues New Shares on Employee Option Exercises and Confirms Regulatory Compliance
PremiumCompany AnnouncementsLumos Diagnostics Issues New Shares on Employee Option Exercises and Confirms Regulatory Compliance
1M ago
LDX
Lumos Diagnostics Seeks Quotation for Additional ASX Shares
Premium
Company Announcements
Lumos Diagnostics Seeks Quotation for Additional ASX Shares
1M ago
LDX
Lumos Director Doug Ward Increases On‑Market Shareholding
Premium
Company Announcements
Lumos Director Doug Ward Increases On‑Market Shareholding
1M ago
LDX
Lumos Diagnostics Files 2026 Corporate Governance Statement with ASX
PremiumCompany Announcements
Lumos Diagnostics Files 2026 Corporate Governance Statement with ASX
2M ago
LDX
Lumos Diagnostics’ FY26 Milestones Expand FebriDx U.S. Market to Over US$1 Billion
PremiumCompany Announcements
Lumos Diagnostics’ FY26 Milestones Expand FebriDx U.S. Market to Over US$1 Billion
2M ago
LDX
Lumos Diagnostics Highlights Point-of-Care Innovation in 2026 Annual Report
PremiumCompany Announcements
Lumos Diagnostics Highlights Point-of-Care Innovation in 2026 Annual Report
2M ago
LDX
Lumos Diagnostics Narrows Annual Loss as Revenue Grows but Going-Concern Risks Persist
PremiumCompany Announcements
Lumos Diagnostics Narrows Annual Loss as Revenue Grows but Going-Concern Risks Persist
2M ago
LDX
Lumos Diagnostics to Showcase Infection-Focused POC Tech at Bioshares Summit
PremiumCompany AnnouncementsLumos Diagnostics to Showcase Infection-Focused POC Tech at Bioshares Summit
2M ago
LDX
Lumos Diagnostics Expands European Reach With FebriDx Deal in Romania
Premium
Company Announcements
Lumos Diagnostics Expands European Reach With FebriDx Deal in Romania
2M ago
LDX
Lumos Diagnostics Updates Market on Director Doug Ward’s Increased Shareholding
Premium
Company Announcements
Lumos Diagnostics Updates Market on Director Doug Ward’s Increased Shareholding
3M ago
LDX
Lumos Diagnostics Issues New Shares Through Employee Option Exercises
PremiumCompany Announcements
Lumos Diagnostics Issues New Shares Through Employee Option Exercises
3M ago
LDX
Lumos Diagnostics Launches Investor Roadshow and Quarterly Results Webinar
PremiumCompany Announcements
Lumos Diagnostics Launches Investor Roadshow and Quarterly Results Webinar
3M ago
LDX
Lumos Diagnostics FY26 Revenue Rises on FebriDx Surge Despite Services Slowdown
PremiumCompany Announcements
Lumos Diagnostics FY26 Revenue Rises on FebriDx Surge Despite Services Slowdown
3M ago
LDX
Lumos Diagnostics Reports Lapse of 43,000 Performance Rights
PremiumCompany Announcements
Lumos Diagnostics Reports Lapse of 43,000 Performance Rights
3M ago
LDX
Lumos Diagnostics Shuts Shareholder Loan as Capital Raise Leaves It Debt-Free
PremiumCompany AnnouncementsLumos Diagnostics Shuts Shareholder Loan as Capital Raise Leaves It Debt-Free
3M ago
LDX
Lumos Diagnostics Secures A$709,837 R&D Tax Rebate to Advance Point-of-Care Platforms
Premium
Company Announcements
Lumos Diagnostics Secures A$709,837 R&D Tax Rebate to Advance Point-of-Care Platforms
3M ago
LDX
Lumos Diagnostics Director Sam Lanyon Increases Shareholding via On‑Market Purchase
Premium
Company Announcements
Lumos Diagnostics Director Sam Lanyon Increases Shareholding via On‑Market Purchase
4M ago
LDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >